Suscripción a Biblioteca: Guest
Critical Reviews™ in Physical and Rehabilitation Medicine

Publicado 4 números por año

ISSN Imprimir: 0896-2960

ISSN En Línea: 2162-6553

SJR: 0.141 SNIP: 0.129 CiteScore™:: 0.6 H-Index: 18

Indexed in

Management of Muscle Spasticity

Volumen 8, Edición 3, 1996, pp. 235-252
DOI: 10.1615/CritRevPhysRehabilMed.v8.i3.50
Get accessGet access

SINOPSIS

Severe muscle spasticity is a common symptom in patients with neurological disability. Although muscle hypertonia in these patients results in impairment of voluntary movements and interferes with motor function, it is often invaluable for the maintenance of trunk posture, weight bearing on the weak lower limbs and ambulation. Other possible beneficial effects of muscle spasticity are prevention of deep vein thrombosis in the paretic limb, maintenance of muscle mass and bone density. Treatment of spasticity should, therefore, follow careful functional assessment of these patients. Common treatment goals are to alleviate painful spasms, to prevent contractures and bone deformities and to improve positioning in a bed or chair. This article reviews various forms of treatment of muscle spasticity including antispasticity drugs, botulinum toxin, chemical neurolysis, surgery and physiotherapy.

CITADO POR
  1. Bakheit A. M. O., Maynard V., Shaw S., The effects of isotonic and isokinetic muscle stretch on the excitability of the spinal alpha motor neurones in patients with muscle spasticity, European Journal of Neurology, 12, 9, 2005. Crossref

  2. Love S. C., Valentine J. P., Blair E. M., Price C. J., Cole J. H., Chauvel P. J., The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial, European Journal of Neurology, 8, s5, 2001. Crossref

  3. Mockford Margaret, Caulton Janette M., The Pathophysiological Basis of Weakness in Children With Cerebral Palsy, Pediatric Physical Therapy, 22, 2, 2010. Crossref

  4. Watanabe Y., Bakheit A. M. O., McIellan D. L., A study of the effectiveness of botulinum toxin type A (Dysport) in the management of muscle spasticity, Disability and Rehabilitation, 20, 2, 1998. Crossref

  5. Kesselring Jürg, Chapter 14 Complications of Multiple Sclerosis: Fatigue; Spasticity; Ataxia; Pain; and Bowel, Bladder, and Sexual Dysfunction, in Multiple Sclerosis 2, 27, 2003. Crossref

  6. Brashear Allison, Gordon Mark F., Elovic Elie, Kassicieh V. Daniel, Marciniak Christina, Do Mai, Lee Chia-Ho, Jenkins Stephen, Turkel Catherine, Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke, New England Journal of Medicine, 347, 6, 2002. Crossref

  7. Krach Linda E., Pharmacotherapy of Spasticity: Oral Medications and Intrathecal Baclofen, Journal of Child Neurology, 16, 1, 2001. Crossref

  8. Weiss Elise, Lin David, Spasticity, in Therapeutic Uses of Botulinum Toxin, 2007. Crossref

  9. Kirkwood Craig A., Bardsley Geoff I., Seating and positioning, in Upper Motor Neurone Syndrome and Spasticity, 2008. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain